##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
||||||31.12.20|31.12.19|
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Total|
||||fund|fund|funds|funds|
|||Notes|||||
|INCOME AND ENDOWMENTS FROM|||||||
|Donations
and legacies||2||||4,550|
|Charitable
activities||4|||||
|To advance the science|and ait ofgynaecological||||||
|oncology for the benefit ofthe public|||51,532||51,532|329,607|
|Investment
income|||144||144|202|
|Total|||51,676||51,676|334,439|
|EXPENDITURE ON|||||||
|Charitable
activities||5|||||
|To advance the science|and art ofgynaecological||||||
|oncology for the benefit ofthe public|||77,229||77,229|209,340|
|NET INCOME/(EXPENDITURE)|||(25,553)||(25,553)|125,099|
|RECONCILIATION|OF FUNDS||||||
|Total funds brought forward|||467,019||467,019|341,920|
|TOTAL FUNDS CARRIED FORWARD|||441,466||441,466|467,019|
##
|||||31.12.20|31.12.19|
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||fund|fund|funds|funds|
||Notes|||||
|CURRENT ASSETS||||||
|Debtors|10|2,040||2,040|151,226|
|Cash at bank||453,469||453,469|340,409|
|||455,509||455,509|491,635|
|CREDITORS||||||
|Amounts
falling due within one year|11|(14,043)||(14,043)|(24,616)|
|NET CURRENT ASSETS||441,466||441,466|467,019|
|TOTAL ASSETSLESSCURRENT||||||
|LIABILITIES||441,466||441,466|467,019|
|NET ASSETS||441,466||441,466|467,019|
|FUNDS|12|||||
|Unrestricted
funds||||441,466|467,019|
|TOTAL FUNDS||||441,466|467,019|
##
##
##
##
##
##
##
||||Unrestricted|Restricted|2020|2019|
|---|---|---|---|---|---|---|
|Mason|Relief Scheme|||||250|
|National|Federation ofGynaeoncology|Nurses||||4300|
|Total||||||4,550|
##
|3.|INVESTMENT INCOME|INVESTMENT INCOME||||
|---|---|---|---|---|---|
|||||31.12.20|31.12.19|
||Deposit account|interest||144|282|
||INCOME FROM CHARITABLE ACTIVITIES|||||
|||||31.12.20|31.12.19|
|||Activity||||
|||To advance the|science and art of|||
|||gynaecological|oncology for the benefit of|||
||Sponsorships|the public||6,883|176,753|
|||To advance the|science and art of|||
|||gynaecological|oncology for the benefit of|||
||Delegate fees|the public||785|114,490|
|||To advance the|science and artof|||
|||gynaecological|oncology for the benefit of|||
||Subscriptions|the public||43,864|38,364|
|||||51,532|329,607|
|5.|CHARITABLE ACTIVITIES COSTS|||||
|||||Support||
||||Direct|costs (see||
||||Costs|note 6)|Totals|
||To advance the|science and art of||||
||gynaecological|oncology for the benefit||||
||ofthe public||59,107|18,122|77&229|
|6.|SUPPORT COSTS|||||
|||||Governance||
||||Management|costs|Totals|
||||||f.|
||To advance the|science and art of||||
||gynaecological|oncology for the benefit of||||
||the public||15,606|2,516|18,122|
##
##
|Independent
examiner's|fees|
|---|---|
|Other assurance
services||
##
##
##
|Trustees'
expenses|||||
|---|---|---|---|---|
||||31.12.20|31.12.19|
||||8||
|Trustees'
expenses|||516|3,304|
|COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES|||||
|||Unrestricted|Restricted|Total|
|||fund|fund|funds|
|INCOME AND ENDOWMENTS FROM|||||
|Donations
and legacies||4,550||4,550|
|Charitable
activities|||||
|To advance the science and art of|||||
|gynaecological
oncology for the benefit ofthe|||||
|public||329,607||329,607|
|Investment
income||282||282|
|Total||334,439||334,439|
|EXPENDITURE ON|||||
|Charitable
activities|||||
|To advance the science and art of|||||
|gynaecological
oncology for the benefit ofthe|||||
|public||209,340||209,340|
|NET INCOME||125,099||125,099|
|RECONCILIATION|OF FUNDS||||
|Total funds brought|forward||||
|As previously
reported||347,854||347,854|
|Prior year adjustment||(5,934)||(5,934)|
|As restated||341,920||341,920|
##
|9.|COMPARATIVES FORTHE|COMPARATIVES FORTHE|COMPARATIVES FORTHE|COMPARATIVES FORTHE|STATEMENT OF FINANCIAL|ACTIVITIES|ACTIVITIES|-continued||
|---|---|---|---|---|---|---|---|---|---|
|||||||Unrestricted||Restricted|Total|
||||||||fund|fund|funds|
|||||||||f||
||TOTAL|FUNDS CARRIED FORWARD||||467,019|||467,019|
|10.|DEBTORS:||AMOUNTS FALLING DUE WITHIN ONE YEAR|||||||
|||||||||31,12.20|31.12.19|
||Other debtors||||||||150,034|
||Prepayrnents|||||||2,040|1,192|
|||||||||2,040|151,226|
|11.|CREDITORS:|||AMOUNTS FALLING DUE WITHIN ONE YEAR||||||
|||||||||31.12.20|31.12.19|
||Trade creditors|||||||11,254|2,081|
||VAT|||||||1,289|20,935|
||Accrued|expenses||||||1,500|1,600|
|||||||||14,043|24,616|
|12.|MOVEMENT|||IN FUNDS||||||
|||||||||Net||
|||||||||movement|At|
|||||||At|1.1.20|in funds|31.12.20|
||Unrestricted||funds|||||||
||General|fund||||467,019||(25,553)|441,466|
||TOTAL|FUNDS||||467,019||(25,553)|441,466|
||Net movement|||in funds, included|in the above are as follows:|||||
|||||||Incoming||Resources|Movement|
|||||||resources||expended|in funds|
||Unrestricted||funds|||||||
||General|fund||||51,676||(77,229)|(25,553)|
||TOTAL|FUNDS||||51,676||(77,229)|(25,553)|
##
|Comparatives|for movement
in fu|nds||||
|---|---|---|---|---|---|
||||Prior|Net||
||||year|movement|At|
|||At 1.1.19|adjustment
f|in funds
6|31.12,19|
|Unrestricted|funds|||||
|General fund||347,854|(5,934)|125,099|467,019|
|TOTAL FUNDS||347,854|(5,934)|125,099|467,019|
||||Incoming|Resources|Movement|
|---|---|---|---|---|---|
||||resources|expended|in funds|
|Unrestricted|funds|||||
|General fund|||334,439|(209,340)|125,099|
|TOTAL FUNDS|||334,439|(209,340)|125,099|
|A current year|12months|and prior year 12months combined|position is as follows:|||
||||Prior|Net||
||||year|movement|At|
|||At 1.1.19|adjustment|in funds|31.12.20|
|Unrestricted|funds|||||
|General fund||347,854|(5,934)|99,546|441,466|
|TOTAL FUNDS||347,854|(5,934)|99,546|441,466|
|as follows:|||||
|---|---|---|---|---|
|||Incoming|Resources|Movement|
|||resources|expended|in funds|
|Unrestricted|funds||||
|General fund||386,115|(286,569)|99,546|
|TOTAL FUNDS||386,115|(286,569)|99,546|
##
##